Advancing regional collaboration and surgeon training in remote robotic-assisted surgery SINGAPORE, Oct. 13, 2025 -- Reach Surgical, the Surgical Solutions division of Genesis MedTech, has facilitated the completion of two robotic telesurgeries using its OMNIBOT robotic-assisted system. Operating from Reach Surgical Institute (RSI) in Santiago, Dr. Roberto Vilches and Dr. Marcelo Kerkebe remotely performed a radical prostatectomy and a partial nephrectomy on patients at Meds Medical Center. These procedures mark an important milestone in advancing robotic t
リモージュ(フランス), 2025年10月13日 -- 1824年創業の象徴的なリモージュ磁器メーカーJL Coquetは、TVS Venu International Holdings Pte Ltdが新たに設立したAtelier Expressionsへの参画により、歴史の新たな章を開きます。シンガポールに拠点を置くAtelier Expressionsは、卓越した企業と伝統的技術の継承を推進することを目的としています。 この戦略的提携は、特に白磁の卓越性で知られる同メーカーにとって大きな前進となります。これは国際展開と職人技の振興への取り組みの一環であり、専門技術の継承とメーカー内での雇用維持に重点を置いています。 「JL Coquetの作品は時代を超えた伝統と完璧な職人技を体現しており、常に感銘を受けてきました」と、Atelier Expressionsのエグゼクティブ・ディレクター、Tara S. Venu氏は述べています。「今回の買収がもたらす可能性に胸を躍らせています。JL Coquetの精神は、卓越した品質と職人技を体現する企業に国際的な認知をもたらすという我々の志と完全に一致しています。」 Sébastien Cich氏がチームと製造スタッ
AI simplifies business management for entrepreneurs Businesses freed from admin to focus on growth Osome to foster robust partner ecosystem SINGAPORE and HONG KONG, Oct. 13, 2025 -- Osome, the AI-enabled business management platform trusted by over 30,000 entrepreneurs globally, has officially entered the United Arab Emirates (UAE) with the opening of its office in Dubai. This move underscores Osome's commitment to alleviating financial and administrative burdens for founders while fostering a collaborative ecosystem of partners in the Middle East. It
KUALA LUMPUR, Malaysia, Oct. 13, 2025 -- Axai Digital Sdn. Bhd. ("Axaipay"), a leading Malaysian fintech company, and E3 Middle East Entrepreneur Network LLC FZ ("E3HUBS") have entered into a Memorandum of Understanding (MoU) during the Expand North Star 2025 event in Dubai, United Arab of Emirates (UAE). The collaboration aims to strengthen cross-border business collaboration and digital payment enablement for UAE-based entrepreneurs expanding into Malaysia and Australia. The signing ceremony was witnessed by Mr. Anuar Fariz Fadzil, Chief Executive Officer
CHENGDU, China, Oct. 12, 2025 -- In the golden September, in the homeland of pandas, the feast of light and shadow commenced once again, as the cultural rendezvous arrived as scheduled. On September 12th and 13th, the 2nd Golden Panda Awards were grandly held in Chengdu. Organized by the China Federation of Literary and Art Circles and the People's Government of Sichuan Province, and permanently hosted in Sichuan, the Golden Panda Awards consistently uphold the purpose of "promoting the building of a community with a shared future for mankind." They are dedicated to f
NEW YORK, Oct. 11, 2025 -- LI-NING, a leading global sportswear and athletic lifestyle company, has signed Egor Dëmin to its roster of athletes under the Way of Wade basketball sub-brand, marking a new era for the company's international division. The partnership was announced by Mr. Li Ning, Founder of the LI-NING brand and the Group's Executive Chairman, together with Dwyane Wade, a 13-year LI-NING Brand Ambassador, during the unveiling of the new Way of Wade 12 in Macau, China, on Saturday night. It was attended by 150 media and influencers. "As we c
HONG KONG, Oct. 11, 2025 -- On October 9, the Office for Attracting Strategic Enterprises (OASES) of the Hong Kong Special Administrative Region (HKSAR) Government hosted a signing ceremony in Hong Kong for a new group of strategic enterprises. Witnessed by Paul Chan, Financial Secretary of the HKSAR, Lianlian DigiTech was named a strategic enterprise partner of the HKSAR Government. Xin Jie, CEO of Lianlian DigiTech, attended the ceremony on behalf of the company and signed an agreement with the HKSAR Government. According to OASES, this round of agreements covers 18 strategic
CHENGDU, China, Oct. 11, 2025 -- C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the National Medical Products Administration (NMPA) for the clinical trial application of [177Lu]-BL-ARC001 Injection, the company's first radiopharmaceutical and a Class 1 innovative biologic. This milestone approval marks Biokin's entry into the fast-growing Radiopharmaceutical Drug Conjugate (RDC) field and reinforces its leadership in large-molecule oncology therapies (ADC/GNC/ARC). The company's flagship asset
HONG KONG, Oct. 11, 2025 -- Global Sources Hong Kong Shows Phase I officially opened today. The first of three phases runs from October 11 to 14 at AsiaWorld-Expo. Under the theme "Where Cutting-Edge Technology Meets Digital Entertainment", the three major international trade shows for gaming, consumer electronics, and electronic components cover categories including audio-visual equipment, automotive electronics, computer peripherals, commercial electronics, outdoor electronics, gaming and esports, electronic components, and batteries and power. The first phase brings together over
CHENGDU, China, Oct. 11, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) was approved for marketing by the National Medical Products Administration (NMPA) for its third indication, the treatment of adult patients with epidermal growth factor receptor (EGFR) mutant-positive locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) who progressed after treatm